LBX Pharmacy Chain JSC
SSE:603883
LBX Pharmacy Chain JSC
Net Income (Common)
LBX Pharmacy Chain JSC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LBX Pharmacy Chain JSC
SSE:603883
|
Net Income (Common)
¥891.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Net Income (Common)
¥1.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Net Income (Common)
¥363.4m
|
CAGR 3-Years
29%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Net Income (Common)
¥1.4B
|
CAGR 3-Years
27%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
Net Income (Common)
¥229.4m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Net Income (Common)
¥1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
See Also
What is LBX Pharmacy Chain JSC's Net Income (Common)?
Net Income (Common)
891.9m
CNY
Based on the financial report for Sep 30, 2023, LBX Pharmacy Chain JSC's Net Income (Common) amounts to 891.9m CNY.
What is LBX Pharmacy Chain JSC's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
16%
Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for LBX Pharmacy Chain JSC have been 14% over the past three years , 16% over the past five years .